Recce Pharmaceuticals Ltd Cash Flow Reinvestment Rate

Latest as of June 2026: 0.10x

Recce Pharmaceuticals Ltd cash flow reinvestment rate. Recce Pharmaceuticals Ltd (RCE) has a Cash Flow Reinvestment Rate of 0.10x as of June 2026, reinvesting AU$34.98K (capex AU$34.98K ) from operating cash flow of AU$341.10K. Explore debt repayment capacity of Recce Pharmaceuticals Ltd to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.10x

(Capex + Investments) / Operating CF

Total Reinvested

AU$34.98K

Capex + Investments

Operating Cash Flow

AU$341.10K

AUD

Capital Expenditures

AU$34.98K

AUD

Cash Flow Reinvestment Rate of Recce Pharmaceuticals Ltd (2014–2014)

Cash flow reinvestment rate of Recce Pharmaceuticals Ltd from 2014 to 2014. Historical reinvestment intensity for Recce Pharmaceuticals Ltd across 1 annual periods. Explore RCE capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Recce Pharmaceuticals Ltd Cash Flow Reinvestment Rate by Year (2014–2014)

Recce Pharmaceuticals Ltd cash flow reinvestment rate by year from 2014 to 2014. Year-by-year capital reinvestment analysis for Recce Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Recce Pharmaceuticals Ltd cash conversion from operations.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2014	3.08x	AU$35.25K	AU$11.43K	AU$35.25K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow